← Leaderboards
Leonid Kagan
Rutgers, The State Univ Of N.J.
$3,344,809
Attributed
$4,101,927
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $785.5K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,101,927 · 2
By mechanism
R01$4,101,927 · 2
Top collaborators
- Scott K Heysell2 shared
Others in their field
Other Emerging Leaders on “Dose”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
Research focus
DoseAntibioticsPharmaceutical PreparationsTreatment FailureDrug KineticsMeasurementSafetyCharacteristicsAdultWeightMathematical ModelAntibodiesCefoxitinLeadImmunoglobulin GDrug UsageAntibiotic ResistanceAffectFatty Acid Glycerol EstersBariatric SurgeryConsensusDrug ModificationDrug ExposureBody Composition
Grant awards (9)
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults$728,725
R01 · FY2025 · AI
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults$785,512
R01 · FY2024 · AI
Mechanisms of obesity-induced changes in drug pharmacokinetics$462,791
R01 · FY2022 · GM · contact PI
Mechanisms of obesity-induced changes in drug pharmacokinetics$464,747
R01 · FY2021 · GM · contact PI
Mechanisms of obesity-induced changes in drug pharmacokinetics$54,739
R01 · FY2021 · GM · contact PI
Mechanisms of obesity-induced changes in drug pharmacokinetics$466,646
R01 · FY2020 · GM · contact PI
Mechanisms of obesity-induced changes in drug pharmacokinetics$468,489
R01 · FY2019 · GM · contact PI
Mechanisms of obesity-induced changes in drug pharmacokinetics$200,000
R01 · FY2019 · GM · contact PI
Mechanisms of obesity-induced changes in drug pharmacokinetics$470,278
R01 · FY2018 · GM · contact PI